Terms: = Liver cancer AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020
13 results:
1. Impact of hospital volume on failure to rescue for complications requiring reoperation after elective colorectal surgery: multicentre propensity score-matched cohort study.
Grönroos-Korhonen MT; Koskenvuo LE; Mentula PJ; Nykänen TP; Koskensalo SK; Leppäniemi AK; Sallinen VJ
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38597158
[TBL] [Abstract] [Full Text] [Related]
2. Racial Disparities in liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
Kilani Y; Kamal SAF; Vikash F; Vikash S; Aldiabat M; Alsakarneh S; Aljabiri Y; Sohail H; Kumar V; Numan L; Al Khalloufi K
Dig Dis Sci; 2023 Oct; 68(10):4050-4059. PubMed ID: 37584869
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma.
Pan Y; Zhang D; Chen Y; Li H; Wang J; Yuan Z; Sun L; Zhou Z; Chen M; Zhang Y; Hu D
J Cell Mol Med; 2023 Apr; 27(7):1006-1020. PubMed ID: 36919714
[TBL] [Abstract] [Full Text] [Related]
4. Prognosis of patients with unresectable stage IV Colon cancer undergoing primary tumor resection: A multicenter study of minimally symptomatic or asymptomatic primary tumor.
Ho MF; Lai VC; Ng DCK; Ng SSM
Asian J Surg; 2023 Sep; 46(9):3710-3715. PubMed ID: 36522225
[TBL] [Abstract] [Full Text] [Related]
5. [Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].
Gao X; Li Z; Shao XY; Liu XM; Liu C; Liu YP; Qu XJ; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):569-573. PubMed ID: 34034477
[No Abstract] [Full Text] [Related]
6. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study.
Chen M; Cao J; Xiang Y; Ma X; Bai Y; Lai Q; Tong C; Ma Z; Topatana W; Hu J; Li S; Juengpanich S; Yu H; Cai X
Surgery; 2021 Jun; 169(6):1304-1311. PubMed ID: 33551070
[TBL] [Abstract] [Full Text] [Related]
7. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
8. [Timeless promotes the proliferation of hepatocellular carcinoma cell by reprogramming of glucose metabolism].
Zhang JS; Yuan P; Yan ZY; Lu R; Li B; Geng XE; Mu J; Zhang HX
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):499-505. PubMed ID: 30060357
[No Abstract] [Full Text] [Related]
9. Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.
Hwang JP; Fisch MJ; Lok AS; Zhang H; Vierling JM; Suarez-Almazor ME
BMC Cancer; 2013 Nov; 13():534. PubMed ID: 24209764
[TBL] [Abstract] [Full Text] [Related]
10. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
[TBL] [Abstract] [Full Text] [Related]
11. Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.
Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
Pharmacogenet Genomics; 2008 Nov; 18(11):1009-15. PubMed ID: 18854779
[TBL] [Abstract] [Full Text] [Related]
12. An updated mortality study of workers at a petroleum refinery in Beaumont, Texas, 1945 to 1996.
Wong O; Harris F; Rosamilia K; Raabe GK
J Occup Environ Med; 2001 Apr; 43(4):384-401. PubMed ID: 11322100
[TBL] [Abstract] [Full Text] [Related]
13. Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
Leichner PK; Klein JL; Siegelman SS; Ettinger DS; Order SE
Cancer Treat Rep; 1983; 67(7-8):647-58. PubMed ID: 6307515
[TBL] [Abstract] [Full Text] [Related]
